To see the other types of publications on this topic, follow the link: Jehovah’s Witness.

Journal articles on the topic 'Jehovah’s Witness'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Jehovah’s Witness.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Wade, Paul. "Jehovah’s Witness." Paediatric Nursing 12, no. 8 (October 1, 2000): 14. http://dx.doi.org/10.7748/paed.12.8.14.s15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Craig, Douglas B. "Jehovah’s witness." Canadian Journal of Anaesthesia 38, no. 6 (September 1991): 801–2. http://dx.doi.org/10.1007/bf03008470.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rollins, KE, U. Contractor, R. Inumerable, and DN Lobo. "Major abdominal surgery in Jehovah’s Witnesses." Annals of The Royal College of Surgeons of England 98, no. 8 (November 2016): 532–37. http://dx.doi.org/10.1308/rcsann.2016.0210.

Full text
Abstract:
Introduction Patients who are Jehovah’s Witnesses pose difficult ethical and moral dilemmas for surgeons because of their refusal to receive blood and blood products. This article outlines the personal experiences of six Jehovah’s Witnesses who underwent major abdominal surgery at a single institution and also summarises the literature on the perioperative care of these patients. Methods The patients recorded their thoughts and the dilemmas they faced during their surgical journey. We also reviewed the recent literature on the ethical principles involved in treating such patients and strategies recommended to make surgery safer. Results All patients were supported in their decision making by the clinical team and the Hospital Liaison Committee for Jehovah’s Witnesses. The patients recognised the ethical and moral difficulties experienced by clinicians in this setting. However, they described taking strength from their belief in Jehovah. A multitude of techniques are available to minimise the risk associated with major surgery in Jehovah’s Witness patients, many of which have been adopted to minimise unnecessary use of blood products in general. Nevertheless, the risks of catastrophic haemorrhage and consequent mortality remain an unresolved issue for the treating team. Conclusions Respect for a patient’s autonomy in this setting is the overriding ethical principle, with detailed discussion forming an important part of the preparation of a Jehovah’s Witness for major abdominal surgery. Clinicians must be diligent in the documentation of the patient’s wishes to ensure all members of the team can abide by these.
APA, Harvard, Vancouver, ISO, and other styles
4

George, James N., Steven A. Sandler, and Joanna Stankiewicz. "Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah’s Witness experience." Blood Advances 1, no. 24 (October 30, 2017): 2161–65. http://dx.doi.org/10.1182/bloodadvances.2017012351.

Full text
Abstract:
Key Points TTP in Jehovah’s Witness patients has been managed successfully without PEX. This experience, plus new TTP treatments, may make it possible for patients who are not Jehovah’s Witnesses to avoid PEX in the future.
APA, Harvard, Vancouver, ISO, and other styles
5

Cox, Roy. "The Jehovah’s Witness Experience." American Annals of the Deaf 155, no. 4 (2010): 517. http://dx.doi.org/10.1353/aad.2010.0023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Noble, William H. "CMPA and Jehovah’s Witness." Canadian Journal of Anaesthesia 38, no. 2 (March 1991): 262–63. http://dx.doi.org/10.1007/bf03008167.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gohari, Pouyan, Abhinav B. Chandra, Richard Slatkin, and Jay S. Lipshitz. "Recovery From Hemoglobin Of 2g/Dl Without Prbc Transfusion: A Lesson Learned From a Jehovah’s Witness With Cold Agglutinin Disease." Blood 122, no. 21 (November 15, 2013): 4657. http://dx.doi.org/10.1182/blood.v122.21.4657.4657.

Full text
Abstract:
Supportive management of critically ill patients with anemia often involves packed red blood cell transfusion. Jehovah’s Witness’ refusal of blood products because of their religious beliefs can render these situations challenging. Successful adaptation of medical management in Jehovah’s Witness’ with severe anemia provides physicians with a distinct opportunity to question common transfusion practices and learn about anemia. We present a case of a 43 year-old Jehovahs Witness who presented with autoimmune hemolytic anemia – cold agglutinin disease. His hemoglobin nadired at 2g/dL. The patient was successfully managed to recovery with corticosteroids, rituximab, folic acid and an erythropoeitin stimulating agent. To our knowledge this is the lowest Hgb that a patient with life threatening cold agglutinin disease survived without the use of any blood product transfusion. Such cases afford a deeper appreciation of the body's ability to adapt to and recover from anemia without the use of exogenous blood. Disclosures: No relevant conflicts of interest to declare.
APA, Harvard, Vancouver, ISO, and other styles
8

Jovanovic, S., S. D. Hansbro, C. M. Munsch, and M. H. Cross. "Redo cardiac surgery in a Jehovah’s Witness, the importance of a multidisciplinary approach to blood conservation." Perfusion 15, no. 3 (May 2000): 251–55. http://dx.doi.org/10.1177/026765910001500311.

Full text
Abstract:
Although Jehovah’s Witnesses present a particular problem when undergoing surgery because of their refusal to accept stored blood, it is now quite common to undertake uncomplicated cardiac surgery in these patients. Complex or redo cardiac surgery however, is often associated with major blood loss, and is conventionally contraindicated in Jehovah’s Witnesses. We describe the perioperative management of a Jehovah’s Witness who underwent a resternotomy for mitral valve replacement and coronary artery bypass grafting having previously had an aortic valve replacement and mitral valve repair. The importance of a multidisciplinary approach to blood conservation is discussed.
APA, Harvard, Vancouver, ISO, and other styles
9

Beck, Alyssa, Robert Lin, Ali Reza Rejali, Muni Rubens, Ronald Paquette, Robert Vescio, Noah Merin, et al. "Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients." Bone Marrow Transplantation 55, no. 6 (January 2, 2020): 1059–67. http://dx.doi.org/10.1038/s41409-019-0777-9.

Full text
Abstract:
AbstractDue to the curative potential and improvement in progression-free survival (PFS), high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is considered the standard of care for several hematologic malignancies, such as multiple myeloma, and lymphomas. ASCT typically involves support with blood product transfusion. Thus, difficulties arise when Jehovah’s Witness patients refuse blood transfusions. In order to demonstrate the safety of performing “bloodless” ASCT (BL-ASCT), we performed a retrospective analysis of 66 Jehovah's Witnesses patients who underwent BL-ASCT and 1114 non-Jehovah’s Witness patients who underwent transfusion-supported ASCT (TF-ASCT) at Cedars-Sinai Medical Center between January 2000 and September 2018. Survival was compared between the two groups. Transplant-related complications, mortality, engraftment time, length of hospital stay, and number of ICU transfers were characterized for the BL-ASCT group. One year survival was found to be 87.9% for both groups (P = 0.92). In the BL-ASCT group, there was one death prior to the 30 days post transplant due to CNS hemorrhage, and one death prior to 100 days due to sepsis. Based on our data, BL-ASCT can be safely performed with appropriate supportive measures, and we encourage community oncologists to promptly refer JW patients for transplant evaluation when ASCT is indicated.
APA, Harvard, Vancouver, ISO, and other styles
10

Fanous, Medhat Y., David Lorenson, Sarah Williams, and Anja K. Jaehne. "Transoral incisionless fundoplication for Jehovah’s Witnesses: A case report discussing safety and durability." SAGE Open Medical Case Reports 5 (January 1, 2017): 2050313X1774886. http://dx.doi.org/10.1177/2050313x17748863.

Full text
Abstract:
Jehovah’s Witness patients pose a unique surgical challenge due to their refusal of transfusion of whole blood or major blood products. One of the surgical strategies is to offer the least invasive approach with the least likelihood of losing blood. In the context of surgical treatment of gastroesophageal reflux disease, endoluminal approaches such as transoral incisionless fundoplication represent an appropriate approach for Jehovah’s Witness patients. This patient is a devout Jehovah’s Witness who was troubled with gastroesophageal reflux disease for many years which was refractory to proton pump inhibitor therapy. Her standard preoperative workup showed that she was a candidate for transoral incisionless fundoplication. Surgery was performed by a transoral incisionless fundoplication certified surgeon and this patient was his second case. Patient had no immediate or long-term complications. She was successfully weaned off proton pump inhibitors. Transoral incisionless fundoplication is an appropriate option for Jehovah’s Witness patients with refractory gastroesophageal reflux disease. This case report shows that the procedure is safe and durable, even in the early stage of the physician’s learning curve.
APA, Harvard, Vancouver, ISO, and other styles
11

Ó Néill, Clayton. "Jehovah’s Witnesses and Blood Transfusions: An Analysis of the Legal Protections Afforded to Adults and Children in European/English Human Rights Contexts." European Journal of Health Law 24, no. 4 (October 19, 2017): 368–89. http://dx.doi.org/10.1163/15718093-12341417.

Full text
Abstract:
Abstract This article considers the degree to which the religious beliefs of Jehovah’s Witnesses are given consideration in European and English courts. Adults’ refusal of blood transfusions is examined within the context of European human rights jurisprudence. A focus is also placed on the position of Jehovah’s Witness children who refuse blood transfusions in the specific context of English medical law due to the prevalence of related case law in this jurisdiction. It is argued that the European Court of Human Rights has given appropriate protection to the will-rights of competent adult Jehovah’s Witnesses who refuse blood transfusions. The position of children is somewhat different, and it is suggested that the courts should give greater consideration to the rights of competent children to manifest their religious beliefs.
APA, Harvard, Vancouver, ISO, and other styles
12

Ellis, Anita. "Consent and the teenage Jehovah’s Witness." Paediatric Nursing 12, no. 3 (April 1, 2000): 29–31. http://dx.doi.org/10.7748/paed.12.3.29.s22.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Conte, John V., and Jonathan B. Orens. "Lung transplantation in a Jehovah’s Witness." Journal of Heart and Lung Transplantation 18, no. 8 (August 1999): 796–800. http://dx.doi.org/10.1016/s1053-2498(99)00031-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Thomas, J. Mervyn. "Postpartum Hemorrhage in a Jehovah’s Witness." Journal of Obstetrics and Gynaecology Canada 33, no. 9 (September 2011): 897. http://dx.doi.org/10.1016/s1701-2163(16)35011-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Mason, C. LaToya, and Connie K. Tran. "Caring for the Jehovah’s Witness Parturient." Anesthesia & Analgesia 121, no. 6 (December 2015): 1564–69. http://dx.doi.org/10.1213/ane.0000000000000933.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Olsen, Kevin R., Ashley L. Screws, and Stephen O. Vose. "Blood Patch in a Jehovah’s Witness." A & A Practice 10, no. 8 (April 2018): 201–3. http://dx.doi.org/10.1213/xaa.0000000000000661.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Jakubowska, Klaudia, Paweł Chruściel, Krzysztof Jurek, Michał Machul, Aneta Kościołek, and Beata Dobrowolska. "Religiosity and Attitudes towards Health, Disease, Death and the Use of Stimulants among Jehovah’s Witnesses." International Journal of Environmental Research and Public Health 18, no. 10 (May 11, 2021): 5049. http://dx.doi.org/10.3390/ijerph18105049.

Full text
Abstract:
Religiosity is considered as one of the many factors shaping an individual’s health consciousness. The aim of the study is an analysis of the correlation between the religiosity of Jehovah’s Witnesses and their attitudes towards health and disease. A cross-sectional study was performed on the convenience sample of 171 Jehovah’s Witnesses from eastern Poland with the use of two research tools: the author’s questionnaire, focusing on attitudes towards health, disease, death and the use of stimulants, and the Duke University Religion Index (DUREL). The research involved 99 females (57.9%) and 72 males (42.1%), with an average age of 37.25 (SD = 12.59) years. On average, they have been a Jehovah’s Witness for 29.21 (SD = 13.22) years and are characterised by a high ratio of organisational religious activity (ORA) (M = 5.60; SD = 0.62) and intrinsic religiosity (IR) (M = 4.81; SD = 0.37). Those who had never smoked before becoming one of Jehovah’s Witnesses had a higher IR (Z = −2.822; p = 0.005), similarly to those respondents who smoked cigarettes before they became Jehovah’s Witnesses (Z = −2.977; p = 0.003) and those who did not abuse alcohol before they became Jehovah’s Witnesses (Z= −1.974; p = 0.048). Jehovah’s Witnesses are a group characterised by a high degree of consistency when it comes to religiosity, attitudes regarding health and disease and health behaviours. This means that they follow the teachings of their religion with regard to health issues. Knowledge about the association between religiosity and health behaviours is important to provide effective health education, health promotion and development of health prevention policy, specifically when dealing with more religious groups of clients.
APA, Harvard, Vancouver, ISO, and other styles
18

Beholz, Sven, Jianshi Liu, Ralf Thoelke, C. Spiess, and Wolfgang Konertz. "Use of desmopressin and erythropoietin in an anaemic Jehovah’s Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement." Perfusion 16, no. 6 (December 2001): 485–89. http://dx.doi.org/10.1177/026765910101600608.

Full text
Abstract:
Cardiac surgery in Jehovah’s Witness patients remains a challenge in the presence of concomitant congenital or acquired coagulation disorders and anaemia. We report a case of a 66-year-old female Jehovah’s Witness suffering from severe calcified aortic valve stenosis requiring aortic valve replacement. The anaemic patient suffered from concomitant platelet dysfunction and deficiency of factors V and VII due to gammopathy of immunoglobulin G. The patient was preoperatively treated with recombinant erythropoietin in combination with folic acid and iron, which resulted in an increase of the haematocrit from 0.335 to 0.416 after 22 days of treatment. Haemostasis was improved by high dose aprotinin and additional desmopressin, which could be demonstrated to be effective by a preoperative test. The patients intra- and postoperative course was uneventful, her total chest tube loss was 130 ml, and she was able to be discharged without the need of any blood transfusions. The beneficial properties of erythropoietin and desmopressin in Jehovah’s Witness patients are discussed.
APA, Harvard, Vancouver, ISO, and other styles
19

Yamamoto, Yumi, Akihito Kawashima, Eri Kashiwagi, and Kiyoyuki Ogata. "A Jehovah’s Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions." Case Reports in Hematology 2014 (2014): 1–4. http://dx.doi.org/10.1155/2014/141260.

Full text
Abstract:
Therapy for acute leukemia in Jehovah’s Witnesses patients is very challenging because of their refusal to accept blood transfusions, a fundamental supportive therapy for this disease. These patients are often denied treatment for fear of treatment-related death. We present the first Jehovah’s Witness patient with acute myeloid leukemia (AML) treated successfully with azacitidine. After achieving complete remission (CR) with one course of azacitidine therapy, the patient received conventional postremission chemotherapy and remained in CR. In the case of patients who accept blood transfusions, there are reports indicating the treatment of AML patients with azacitidine. In these reports, azacitidine therapy was less toxic, including hematoxicity, compared with conventional chemotherapy. The CR rate in azacitidine-treated patients was inadequate; however, some characteristics could be useful in predicting azacitidine responders. The present case is useful for treating Jehovah’s Witnesses patients with AML and provides a clue for anti-AML therapy requiring minimum blood transfusions.
APA, Harvard, Vancouver, ISO, and other styles
20

Conti, Adelaide, Emanuele Capasso, Claudia Casella, Piergiorgio Fedeli, Francesco Antonio Salzano, Fabio Policino, Lucia Terracciano, and Paola Delbon. "Blood transfusion in children: the refusal of Jehovah’s Witness parents’." Open Medicine 13, no. 1 (April 5, 2018): 101–4. http://dx.doi.org/10.1515/med-2018-0016.

Full text
Abstract:
AbstractIn Italy, both parents have parental responsibility; as a general principle they have the power to give or withhold consent to medical procedures on their children, including consent for blood transfusion; however these rights are not absolute and exist only to promote the welfare of children.MethodsThe Authors discuss ethical and legal framework for Jehovah’s Witness parents’ refusal of blood transfusion in Italy. They searched national judgments concerning Jehovah’s Witness parents’ refusal of blood transfusion – and related comments – in national legal databases and national legal journals, and literature on medical literature databases.ResultsIn the case of Jehovah’s Witness parents’ refusal of blood transfusion for their child, Italian Courts adopt measures that prevents the parents from exercise their parental responsibility not in the child’s best interest.DiscussionIn the event that refusal by the parents, outside of emergency situations, exposes the child’s health to serious risk, health workers must proceed by notifying the competent authority, according also to the Italian Code of Medical Ethics.ConclusionWhen the patient is a minor, the child’s best interest always come first.
APA, Harvard, Vancouver, ISO, and other styles
21

Lanthaler, M., M. Freund, R. Margreiter, and H. Nehoda. "Unusual impalement injury in a Jehovah’s Witness." Journal of Thoracic and Cardiovascular Surgery 129, no. 5 (May 2005): 1179–80. http://dx.doi.org/10.1016/j.jtcvs.2004.09.022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

TROUWBORST, A., R. R. P. M. HAGENOUW, J. JEEKEL, and G. L. ONG. "HYPERVOLAEMIC HAEMODILUTION IN AN ANAEMIC JEHOVAH’S WITNESS." British Journal of Anaesthesia 64, no. 5 (May 1990): 646–48. http://dx.doi.org/10.1093/bja/64.5.646.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kholaki, Omar, Todd R. Wentland, and Roderick Y. Kim. "Substernal goiter excision in a Jehovah’s Witness." Baylor University Medical Center Proceedings 33, no. 3 (March 30, 2020): 462–64. http://dx.doi.org/10.1080/08998280.2020.1739483.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

McMullan, David Michael, Erik A. K. Beyer, Igor Gregoric, Branislav Radovancevic, and O. H. Frazier. "Left ventricular reduction in a Jehovah’s Witness." Annals of Thoracic Surgery 70, no. 3 (September 2000): 958–60. http://dx.doi.org/10.1016/s0003-4975(00)01717-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

SHAW, HOWARD A., and EMEKA EZENWA. "Secondary Abdominal Pregnancy in a Jehovah’s Witness*." Southern Medical Journal 93, no. 9 (September 2000): 898–900. http://dx.doi.org/10.1097/00007611-200009000-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

RIVEROS-PEREZ, EFRAIN, and RACHEL KACMAR. "Peripartum Care of the Jehovah’s Witness Patient." Clinical Obstetrics and Gynecology 60, no. 2 (June 2017): 394–404. http://dx.doi.org/10.1097/grf.0000000000000271.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Waters, Jonathan H., and Paul S. Potter. "Cell Salvage in the Jehovah’s Witness Patient." Anesthesia & Analgesia 90, no. 1 (January 2000): 229–30. http://dx.doi.org/10.1097/00000539-200001000-00053.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Booke, Michael. "Cell Salvage in the Jehovah’s Witness Patient." Anesthesia & Analgesia 90, no. 1 (January 2000): 230. http://dx.doi.org/10.1097/00000539-200001000-00054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Raman, Shankar R., Vellore S. Parithivel, and John M. Cosgrove. "Emergency Subtotal Colectomy in a Jehovah’s Witness With Massive Lower Gastrointestinal Bleeding: Challenges Encountered and Lessons Learned." American Journal of Critical Care 20, no. 2 (March 1, 2011): 176–78. http://dx.doi.org/10.4037/ajcc2011498.

Full text
Abstract:
A 66-year-old woman who was a Jehovah’s Witness had massive lower gastrointestinal bleeding and subsequent hypovolemic shock, necessitating a subtotal colectomy. During the postoperative period, her hemoglobin level decreased to a low of 2.6 g/dL, prolonging her dependence on mechanical ventilation. Prudent perioperative care resulted in a successful outcome. Blood-conserving techniques are indispensable in the management of Jehovah’s Witnesses who have massive blood loss. Maximizing oxygen transport, minimizing blood loss, using a cell saver when permissible, providing optimal ventilatory support, performing tracheostomy early if prolonged mechanical ventilation is expected, and augmenting hemoglobin production with administration of iron and erythropoietin are techniques that can facilitate successful outcome in patients who refuse blood transfusion.
APA, Harvard, Vancouver, ISO, and other styles
30

Jordan, Shane D., and Earnest Alexander. "Bovine Hemoglobin." Journal of Pharmacy Practice 26, no. 3 (August 6, 2012): 257–60. http://dx.doi.org/10.1177/0897190012451928.

Full text
Abstract:
Introduction: Management of severe symptomatic anemia in critically ill Jehovah’s Witness patients remains a challenge. The paucity of therapeutic alternatives to human red blood cells has prompted the use of blood substitutes. Case Report: A 19-year-old female Jehovah’s Witness patient presented to the emergency department following several episodes of syncope. She was found to have a positive Coombs test and was diagnosed with warm-bodied autoimmune hemolytic anemia. Upon admission, her hemoglobin was 8.4 g/dL, then dropped to a nadir of 2.8 g/dL 4 days later. She received traditional management with corticosteroids, intravenous immune globulin, rituximab, and partial splenic artery embolization. Despite these therapies, hemoglobin levels failed to respond, and she experienced signs of marked ischemia. A decision was made to give 2 units of Hemopure, a bovine hemoglobin-based oxygen carrier, and the hemoglobin levels increased to 8.7 g/dL 10 days later. The patient’s overall clinical condition improved leading to subsequent hospital discharge. Conclusion: This case exemplifies the ingenuity that health care practitioners must use in critical situations involving the medical management of anemic Jehovah’s Witness patients who refuse blood products. Hemopure was used as “bridging treatment” to help save a patient from the devastating effects of ischemia resulting from severe anemia.
APA, Harvard, Vancouver, ISO, and other styles
31

Fernandez-Trujillo, Liliana, Fernando Sanabria, Diego F. Bautista, Mauricio Velazquez, Indira Cujiño, Eric Tafur, Daniel Arboleda, Valeria Zuñiga-Restrepo, and Willian Martinez. "First Lung Transplantation in Jehovah’s Witness Patient in Latin America." Clinical Medicine Insights: Case Reports 13 (January 2020): 117954762094073. http://dx.doi.org/10.1177/1179547620940737.

Full text
Abstract:
Lung transplantation is a life-saving alternative for patients with end-stage lung disease. The procedure itself has a high risk of bleeding. Jehovah’s Witness patients refuse to accept blood products due to religious beliefs. A 48-year-old Jehovah’s Witness woman presented with an 8-year history of cough, dyspnea along with progressive worsening of her functional class and quality of life. A diagnosis of autoimmune interstitial lung disease was made, for which cyclophosphamide was administered without improvement of symptoms, and the patient was accepted as a transplant candidate. Transplantation was performed without complications, nor blood products requirement, intraoperative cell salvage was performed, and pharmacological agents were used preoperatively for bleeding prevention. The patient only developed anemia after administration of immunosuppressor therapy, which was treated with erythropoietin in the outpatient setting.
APA, Harvard, Vancouver, ISO, and other styles
32

Saligram, Shreyas, Madhav Desai, and Leonard Baidoo. "Management of Inflammatory Bowel Diseases in Jehovah’s Witness." Gastro - Open Journal 1, no. 5 (December 31, 2015): 114–18. http://dx.doi.org/10.17140/goj-1-120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Weiner, Lindsay, George Willis, Zachary Dezman, and Laura Bontempo. "52-Year-Old Jehovah’s Witness Female with Weakness." Clinical Practice and Cases in Emergency Medicine 2, no. 2 (April 20, 2018): 103–8. http://dx.doi.org/10.5811/cpcem.2018.3.37699.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Nash, Michael J., and Hannah Cohen. "Management of Jehovah’s Witness patients with haematological problems." Blood Reviews 18, no. 3 (September 2004): 211–17. http://dx.doi.org/10.1016/s0268-960x(03)00065-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Tasch, James, and Pedro Gonzalez-Zayaz. "Ceftriaxone-Induced Hemolytic Anemia in a Jehovah’s Witness." American Journal of Case Reports 18 (2017): 431–35. http://dx.doi.org/10.12659/ajcr.903507.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Khan, Rafiullah, Sarah L. Mott, Allyson Schultz, Y. S. Jethava, and Guido Tricot. "Bloodless tandem autologous transplant in Jehovah’s Witness patients." Bone Marrow Transplantation 53, no. 11 (May 24, 2018): 1428–33. http://dx.doi.org/10.1038/s41409-018-0132-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Rajewska, Aleksandra, Wioletta Mikołajek-Bedner, Małgorzata Sokołowska, Joanna Lebdowicz, Sebastian Kwiatkowski, and Andrzej Torbè. "The Jehovah’s Witness obstetric patient – a literature review." Anaesthesiology Intensive Therapy 51, no. 5 (2019): 390–403. http://dx.doi.org/10.5114/ait.2019.90991.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Eun, Daniel D. "Robotic Partial Nephrectomy in a Jehovah’s Witness Population." Journal of Urology and Nephrology Open Access 1, no. 1 (September 1, 2015): 1–5. http://dx.doi.org/10.15226/2473-6430/1/1/00102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Dallas, Torijaun, Ian Welsby, Brandi Bottiger, Carmelo Milano, Mani Daneshmand, and Nicole Guinn. "Bloodless Orthotopic Heart Transplantation in a Jehovah’s Witness." A & A Case Reports 4, no. 10 (May 2015): 140–42. http://dx.doi.org/10.1213/xaa.0000000000000067.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Lim, Ming Y., and Charles S. Greenberg. "Successful Management of Thrombotic Thrombocytopenic Purpura in a Jehovah’s Witness: An Individualized Approach With Joint Decision-Making." Journal of Patient Experience 7, no. 1 (February 14, 2019): 8–11. http://dx.doi.org/10.1177/2374373519829902.

Full text
Abstract:
The management of thrombotic thrombocytopenic purpura (TTP) presents a unique challenge in individuals who are unable to accept plasma due to religious beliefs, given that therapeutic plasma exchange (TPE) is the standard of care. A 61-year-old Jehovah’s Witness woman presented to our hospital with neurological symptoms and laboratory findings suggestive of TTP. On admission, she refused transfusion of blood products, specifically red blood cells, platelets, and plasma but accepted albumin and intravenous immunoglobulin (IVIG); fractions of plasma. She was started on steroids, IVIG, and TPE with albumin as replacement therapy with minimal improvement. After a detailed discussion with the patient and family, they agreed to accept cryosupernatant. The patient started TPE with cryosupernatant for replacement therapy, which resulted in clinical improvement. This case highlights the importance of an individualized approach with joint decision-making given the significant heterogeneity that exists in Jehovah’s Witnesses’ attitude toward the receipt of blood products.
APA, Harvard, Vancouver, ISO, and other styles
41

Wilson, Phil. "Jehovah’s Witness children: when religion and the law collide." Paediatric Care 17, no. 3 (April 2005): 34–37. http://dx.doi.org/10.7748/paed2005.04.17.3.34.c978.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Eleje, GU, OO Okonkwo, and JE Okonkwo. "Gestational Choriocarcinoma in a Jehovah’s Witness: A Case Report." Journal of Gynecological Research and Obstetrics 1, no. 1 (November 9, 2015): 010–12. http://dx.doi.org/10.17352/jgro.000003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Wilson, Phil. "Jehovah’s witness children: when religion and the law collide." Paediatric Nursing 17, no. 3 (April 2005): 34–37. http://dx.doi.org/10.7748/paed.17.3.34.s20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Barsun, Alura, Soman Sen, Tina L. Palmieri, and David G. Greenhalgh. "Reducing Postburn Injury Anemia in a Jehovah’s Witness Patient." Journal of Burn Care & Research 35, no. 4 (2014): e258-e261. http://dx.doi.org/10.1097/bcr.0b013e3182a366c5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Effa-Heap, Gladys. "Blood transfusion: implications of treating a Jehovah’s Witness patient." British Journal of Nursing 18, no. 3 (February 12, 2009): 174–77. http://dx.doi.org/10.12968/bjon.2009.18.3.39047.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Shaner, D. Malcolm, and Jateen Prema. "Conversation and the Jehovah’s Witness Dying From Blood Loss." Narrative Inquiry in Bioethics 4, no. 3 (2014): 253–61. http://dx.doi.org/10.1353/nib.2014.0071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Strum, Earl, Nicolas Jabbour, Gagandeep Singh, and Rick Selby. "Transplantation in Jehovah’s witness population: bloodless surgery allows options." Seminars in Anesthesia, Perioperative Medicine and Pain 23, no. 1 (March 2004): 66–70. http://dx.doi.org/10.1053/j.sane.2003.12.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Elmistekawy, Elsayed, Thierry G. Mesana, and Marc Ruel. "Should Jehovah’s Witness patients be listed for heart transplantation?" Egyptian Heart Journal 66, no. 1 (March 2014): 23. http://dx.doi.org/10.1016/j.ehj.2013.12.065.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Shukunami, Ken-ichi, Koji Nishijima, Makoto Orisaka, Yoshio Yoshida, and Fumikazu Kotsuji. "Acute abdomen in a Jehovah’s witness with chronic anemia." American Journal of Emergency Medicine 22, no. 3 (May 2004): 242–43. http://dx.doi.org/10.1016/j.ajem.2004.02.026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Dalal, Shail, Manoranjan Boddapati, Mary N. Lowery, Diana M. Veillon, Jonathan Glass, and Reinhold Munker. "Treatment of acute myeloid leukemia in a Jehovah’s Witness." Annals of Hematology 85, no. 6 (March 4, 2006): 407–8. http://dx.doi.org/10.1007/s00277-006-0087-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography